Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 3/20 | 0.36 |
| ▸ | GPR3 | P46089 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 2/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | HTR1A | P08908 | 1/20 | 0.34 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | DRD1 | P21728 | 1/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.34 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.34 |
| ▸ | DRD3 | P35462 | 1/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.34 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.34 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.33 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.32 |
| ▸ | BCHE | P06276 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8535341 | 0.76 | GPR3 (0.34) | GPR3ACHECHRM2HTR1AADRA2A | |
| SCHEMBL7718899 | 0.76 | HTR6 (0.36) | HTR6GPR3ACHECHRM2HTR1A | |
| SCHEMBL5473851 | 0.74 | GPR3 (0.33) | GPR3ACHECHRM2HTR1AADRA2A | |
| SCHEMBL7618536 | 0.74 | HTR6 (0.39) | HTR6GPR3ACHECHRM2HTR1A | |
| SCHEMBL6445149 | 0.72 | HTR6 (0.39) | HTR6GPR3SLC22A2SLC22A3HTR2A | |
| SCHEMBL7624281 | 0.71 | HTR6 (0.47) | HTR6GPR3ACHECHRM2HTR1A | |
| SCHEMBL8158527 | 0.70 | ACHE (0.39) | HTR6GPR3ACHECHRM2HTR1A | |
| SCHEMBL8158524 | 0.69 | PTPN1 (0.41) | HTR6GPR3ACHEBCHE | |
| SCHEMBL6475443 | 0.69 | HTR6 (0.38) | HTR6GPR3 | |
| SCHEMBL7630387 | 0.69 | HTR6 (0.36) | HTR6GPR3ACHECHRM2HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1017729-B1 | PROCESS FOR THE PREPARATION OF SUBSTANTIALLY AMORPHOUS ALPHA-OLEFIN POLYMERS, COMPOSITIONS CONTAINING THEM AND PROCESS FOR THE PREPARATION OF BRIDGED LIGAND | BASELL POLYOLEFINE GMBH (DE) | 2005-09-14 | — | — | EP | disclosed |
| US-6844288-B2 | Process for the preparation of ligands for metallogene catalysts | BASELL POLYOLEFINE GMBH (DE) | 2005-01-18 | — | — | US | disclosed |
| EP-0991677-B1 | PROCESS FOR THE PREPARATION OF COPOLYMERS OF ETHYLENE WITH ALPHA-OLEFINS | BASELL POLYOLEFINE GMBH (DE) | 2004-06-16 | — | — | EP | disclosed |
| US-20030158356-A1 | Process for the preparation of substantially amorphous alpha-olefin polymers and compositions containing them and process for the preparation of bridged ligand | EQUISTAR CHEMICALS, LP | 2003-08-21 | — | — | US | disclosed |
| US-20020169260-A1 | Process for the preparation of ligands for metallocene catalysts | RESCONI LUIGI (IT) | 2002-11-14 | — | — | US | disclosed |
| US-20020156209-A1 | Polymerization in the presence of metallocene catalysts with bridged bis-indenyl compounds | BASELL TECHNOLOGY COMANY BV (NL) | 2002-10-24 | — | — | US | disclosed |
| US-6448350-B1 | Process for the preparation of copolymers of ethylene with alpha-olefins | BASELL TECHNOLOGY COMPANY BV (NL) | 2002-09-10 | — | — | US | disclosed |
| US-6423796-B1 | COORDINATION CATALYST | BASEL TECHNOLOGY COMPANY BV (NL) | 2002-07-23 | — | — | US | disclosed |
| EP-0920403-B1 | PROCESS FOR PREPARING CYCLOPENTADIENYL COMPOUNDS | BASELL TECHNOLOGY CO BV (NL) | 2002-01-30 | — | — | EP | disclosed |
| US-6268518-B1 | AS POLYMERIZATION CATALYSTS FOR POLYMERIZATION OF OLEFINS | MONTELL TECHNOLOGY COMPANY B.V. (NL) | 2001-07-31 | — | — | US | disclosed |
| US-6162937-A | Process for preparing cyclopentadienyl compounds | MONTELL TECHNOLOGY COMPANY B.V. (NL) | 2000-12-19 | — | — | US | disclosed |
| WO-2000001738-A9 | PROCESS FOR THE PREPARATION OF SUBSTANTIALLY AMORPHOUS ALPHA-OLEFIN POLYMERS, COMPOSITIONS CONTAINING THEM AND PROCESS FOR THE PREPARATION OF BRIDGED LIGAND | MONTELL TECHNOLOGY COMPANY BV (NL) | 2000-07-27 | — | — | WO | disclosed |
| EP-1017729-A2 | PROCESS FOR THE PREPARATION OF SUBSTANTIALLY AMORPHOUS ALPHA-OLEFIN POLYMERS, COMPOSITIONS CONTAINING THEM AND PROCESS FOR THE PREPARATION OF BRIDGED LIGAND | Montell Technology Company bv (NL) | 2000-07-12 | — | — | EP | disclosed |
| EP-0991677-A1 | PROCESS FOR THE PREPARATION OF COPOLYMERS OF ETHYLENE WITH ALPHA-OLEFINS | Montell Technology Company bv (NL) | 2000-04-12 | — | — | EP | disclosed |
| WO-2000001738-A2 | PROCESS FOR THE PREPARATION OF SUBSTANTIALLY AMORPHOUS ALPHA-OLEFIN POLYMERS, COMPOSITIONS CONTAINING THEM AND PROCESS FOR THE PREPARATION OF BRIDGED LIGAND | MONTELL TECHNOLOGY COMPANY BV (NL) | 2000-01-13 | — | — | WO | disclosed |
| WO-1999054369-A1 | PROCESS FOR THE PREPARATION OF COPOLYMERS OF ETHYLENE WITH ALPHA-OLEFINS | MONTELL TECHNOLOGY COMPANY B.V. (NL) | 1999-10-28 | — | — | WO | disclosed |
| EP-0920403-A1 | PROCESS FOR PREPARING CYCLOPENTADIENYL COMPOUNDS | Montell Technology Company bv (NL) | 1999-06-09 | — | — | EP | disclosed |
| EP-0914323-A1 | METALLOCENES AND CATALYSTS FOR POLYMERIZATION OF OLEFINS | Montell Technology Company B.V. (NL) | 1999-05-12 | — | — | EP | disclosed |
| WO-1998043989-A1 | METALLOCENES AND CATALYSTS FOR POLYMERIZATION OF OLEFINS | MONTELL TECHNOLOGY COMPANY B.V. (NL) | 1998-10-08 | — | — | WO | disclosed |
| WO-1998043931-A1 | PROCESS FOR PREPARING CYCLOPENTADIENYL COMPOUNDS | MONTELL TECHNOLOGY COMPANY B.V. (NL) | 1998-10-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030158356-A1 | Process for the preparation of substantially amorphous alpha-olefin polymers and compositions containing them and process for the preparation of bridged ligand | MACF1, SDC1, SDC2 | HTR6 4576/4885GPR3 3819/4885ACHE 4508/4885 |
| US-20020169260-A1 | Process for the preparation of ligands for metallocene catalysts | SDC1, SDC2, SDC4 | HTR6 4211/4885GPR3 4124/4885ACHE 4573/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.